Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP610750.RA5uNS_nnQv9Gu5ZRvVVC3EMXyK0KWJqBpT6xrf1D4AyA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP610750.RA5uNS_nnQv9Gu5ZRvVVC3EMXyK0KWJqBpT6xrf1D4AyA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP610750.RA5uNS_nnQv9Gu5ZRvVVC3EMXyK0KWJqBpT6xrf1D4AyA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP610750.RA5uNS_nnQv9Gu5ZRvVVC3EMXyK0KWJqBpT6xrf1D4AyA130_provenance.
- NP610750.RA5uNS_nnQv9Gu5ZRvVVC3EMXyK0KWJqBpT6xrf1D4AyA130_assertion description "[P-glycoprotein is a product of the multidrug resistance (MDR1) gene, which is a major cause of the refractoriness of malignant lymphomas to conventional chemotherapeutic regimens containing anthracycline.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP610750.RA5uNS_nnQv9Gu5ZRvVVC3EMXyK0KWJqBpT6xrf1D4AyA130_provenance.
- NP610750.RA5uNS_nnQv9Gu5ZRvVVC3EMXyK0KWJqBpT6xrf1D4AyA130_assertion evidence source_evidence_literature NP610750.RA5uNS_nnQv9Gu5ZRvVVC3EMXyK0KWJqBpT6xrf1D4AyA130_provenance.
- NP610750.RA5uNS_nnQv9Gu5ZRvVVC3EMXyK0KWJqBpT6xrf1D4AyA130_assertion SIO_000772 23768637 NP610750.RA5uNS_nnQv9Gu5ZRvVVC3EMXyK0KWJqBpT6xrf1D4AyA130_provenance.
- NP610750.RA5uNS_nnQv9Gu5ZRvVVC3EMXyK0KWJqBpT6xrf1D4AyA130_assertion wasDerivedFrom befree-20140225 NP610750.RA5uNS_nnQv9Gu5ZRvVVC3EMXyK0KWJqBpT6xrf1D4AyA130_provenance.
- NP610750.RA5uNS_nnQv9Gu5ZRvVVC3EMXyK0KWJqBpT6xrf1D4AyA130_assertion wasGeneratedBy ECO_0000203 NP610750.RA5uNS_nnQv9Gu5ZRvVVC3EMXyK0KWJqBpT6xrf1D4AyA130_provenance.
- befree-20140225 importedOn "2014-02-25" NP610750.RA5uNS_nnQv9Gu5ZRvVVC3EMXyK0KWJqBpT6xrf1D4AyA130_provenance.